0
USD ▼
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

COVID-19 Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, and Product Type - Product Thumbnail Image

COVID-19 Vaccine Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, and Product Type

  • Report
  • January 2024
  • 101 Pages
  • Global
From
EUR$4,013USDGBP
Global Pediatric Vaccines Market By Type, By Technology, By Indication: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Global Pediatric Vaccines Market By Type, By Technology, By Indication: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • November 2022
  • 310 Pages
  • Global
From
EUR$3,840USDGBP
Asia Pacific Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030

  • Report
  • December 2023
  • 138 Pages
  • Asia Pacific
From
EUR$1,500USDGBP
North America Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030

  • Report
  • December 2023
  • 126 Pages
  • North America
From
EUR$1,500USDGBP
Europe Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030

  • Report
  • December 2023
  • 136 Pages
  • Europe
From
EUR$1,500USDGBP
LAMEA Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Vaccine Adjuvants Market Size, Share & Industry Trends Analysis Report By Type (Particulate, Adjuvant Emulsion, Pathogen, Combination, and Others), By Administration, By Application, By Country and Growth Forecast, 2023 - 2030

  • Report
  • December 2023
  • 137 Pages
  • Middle East, Africa
From
EUR$1,500USDGBP
Recombinant Vaccines Market By Indication, By End User, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031 - Product Thumbnail Image

Recombinant Vaccines Market By Indication, By End User, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031

  • Report
  • October 2022
  • 258 Pages
  • Global
From
EUR$3,570USDGBP
Vaccines Global Market Opportunities And Strategies To 2031 - Product Thumbnail Image

Vaccines Global Market Opportunities And Strategies To 2031

  • Report
  • January 2023
  • 343 Pages
  • Global
From
EUR$3,500USDGBP
EUR$5,000USDGBP
Human Vaccine Adjuvant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Human Vaccine Adjuvant Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • October 2023
  • 92 Pages
  • Global
From
EUR$4,013USDGBP
Influenza Vaccine Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Influenza Vaccine Market - Forecasts from 2022 to 2027

  • Report
  • March 2022
  • 124 Pages
  • Global
From
EUR$4,450USDGBP
H7N9 Vaccine Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

H7N9 Vaccine Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • July 2023
  • 87 Pages
  • Global
From
EUR$4,013USDGBP
Vaccines Delivery Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Vaccines Delivery Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 80 Pages
  • Global
From
EUR$4,013USDGBP
Virus Like Particle Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Virus Like Particle Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • April 2023
  • 136 Pages
  • Global
From
EUR$4,013USDGBP
EU COVID-19 Vaccine and Therapeutics Insights, Trends, and Growth Opportunities - Product Thumbnail Image

EU COVID-19 Vaccine and Therapeutics Insights, Trends, and Growth Opportunities

  • Report
  • November 2021
  • 55 Pages
  • Europe
From
EUR$2,450USDGBP
Vaccines Market - Global Industry Analysis (2019 - 2021), Growth Trends, and Market Forecast (2023 - 2029) - Product Thumbnail Image

Vaccines Market - Global Industry Analysis (2019 - 2021), Growth Trends, and Market Forecast (2023 - 2029)

  • Report
  • November 2022
  • 160 Pages
  • Global
EUR$3,400USDGBP
Respiratory Syncytial Virus (RSV): Forecast in Asia-Pacific Markets to 2028 - Product Thumbnail Image

Respiratory Syncytial Virus (RSV): Forecast in Asia-Pacific Markets to 2028

  • Report
  • November 2019
  • 153 Pages
  • Asia Pacific
From
EUR$8,995USDGBP
Human Papillomavirus Vaccine Market by Disease Indication, Type, Distribution Channel - Global Forecast 2025-2030 - Product Thumbnail Image

Human Papillomavirus Vaccine Market by Disease Indication, Type, Distribution Channel - Global Forecast 2025-2030

  • Report
  • October 2024
  • 185 Pages
  • Global
From
EUR$3,545USDGBP
EUR$3,939USDGBP
Coronavirus (COVID-19) Current Therapy Global Market Report 2023 - Product Thumbnail Image

Coronavirus (COVID-19) Current Therapy Global Market Report 2023

  • Report
  • February 2023
  • 250 Pages
  • Global
From
EUR$5,000USDGBP
Respiratory Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Respiratory Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 250 Pages
  • Global
From
EUR$3,995USDGBP
mRNA Vaccines in Infectious Diseases Market Overview - Product Thumbnail Image

mRNA Vaccines in Infectious Diseases Market Overview

  • Report
  • December 2023
  • 76 Pages
  • Global
From
EUR$995USDGBP
Loading Indicator
This website uses cookies to ensure you get the best experience. Learn more